🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: olodaterol 2.5 mcg

Found 9 matching trials

INvestigating COPD Outcomes, Genomics and Neutrophilic Inflammation With Tiotropium and Olodaterol

PHASE4

This protocol describes a randomised controlled trial to test the hypothesi...

Status

Completed

Location

NHS Tayside

Start Date

2017-06-01

Trial ID

NCT03152149

Treatments Being Tested

Tiotropium & olodaterol fluticasone furoate & vilanterol

An Efficacy Study of Umeclidinium/Vilanterol With Tiotropium/Olodaterol in COPD Patients

PHASE4

The primary objective of this study is to assess the effect of umeclidinium...

Status

Completed

Location

GSK Investigational Site

Start Date

2016-07-14

Trial ID

NCT02799784

Treatments Being Tested

UMEC/VI TIO/OLO Albuterol/salbutamol

Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients.

PHASE3

The primary objective of this trial is to investigate the effect of 6 weeks...

Status

Completed

Location

1237.14.01404 Boehringer Ingelheim Investigational Site

Start Date

2012-02

Trial ID

NCT01533935

Treatments Being Tested

Placebo Tiotropium + Olodaterol tiotropium + Olodaterol Tiotropium Olodaterol Respimat

Ultra-long Acting Bronchodilator Therapy in Smoking Asthmatics

PHASE4

Single centre, open-label, random order, cross-over trial, recruited over a...

Status

Completed

Location

Scottish Centre for Respiratory Research, University of Dundee, Ninewells Hospital and Medical School

Start Date

2016-07-11

Trial ID

NCT02682862

Treatments Being Tested

olodaterol hydrochloride 2.5mcg, tiotropium bromide 2.5mcg olodaterol 2.5 mcg

Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients

PHASE3

The primary objective of this trial is to investigate the effect of 6 weeks...

Status

Completed

Location

1237.13.01302 Boehringer Ingelheim Investigational Site

Start Date

2012-03

Trial ID

NCT01533922

Treatments Being Tested

Placebo Tiotropium Olodaterol tiotropium + olodaterol Tiotropium + Olodaterol Respimat

Effect of Treatment BI 1744 CL (5 and 10 mcg) Versus Placebo on Exercise Endurance Time During Constant Work Rate Cycle Ergometry I

PHASE3

To compare the effects of BI 1744 CL versus placebo on exercise tolerance a...

Status

Completed

Location

1222.37.6171 Boehringer Ingelheim Investigational Site

Start Date

2010-01

Trial ID

NCT01040130

Treatments Being Tested

Olodaterol (BI 1744)Olodaterol (BI 1744)Placebo Olodaterol (BI 1744)Olodaterol (BI 1744) Placebo

12 / 48 Week Pivotal PFT vs PBO in COPD I

PHASE3

This primary objective of this study is to compare two doses of BI 1744 CL ...

Status

Completed

Location

1222.11.1122 Boehringer Ingelheim Investigational Site

Start Date

2008-11

Trial ID

NCT00782210

Treatments Being Tested

Olodaterol (BI1744)Olodaterol (BI1744)placebo

Effect of Treatment BI 1744 CL (5 and 10 mcg) Versus Placebo on Exercise Endurance Time During Constant Work Rate Cycle Ergometry II

PHASE3

To compare the effects of BI 1744 CL versus placebo on exercise tolerance a...

Status

Completed

Location

1222.38.4380 Boehringer Ingelheim Investigational Site

Start Date

2010-01

Trial ID

NCT01040793

Treatments Being Tested

Olodaterol (BI 1744)Olodaterol (BI 1744)Placebo Olodaterol (BI1744)Olodaterol (BI 1744) placebo

12 / 48 wk Pivotal PFT vs PBO in COPD II

PHASE3

This primary objective of this study is to compare two doses of BI 1744 CL ...

Status

Completed

Location

1222.12.1227 Boehringer Ingelheim Investigational Site

Start Date

2009-02

Trial ID

NCT00782509

Treatments Being Tested

Olodaterol (BI 1744)Olodaterol (BI 1744)Placebo

Previous Next